Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 | P04150 | 4/20 | 0.61 |
| ▸ | PGR | P06401 | 3/20 | 0.61 |
| ▸ | AR | P10275 | 2/20 | 0.61 |
| ▸ | TRPV1 | Q8NER1 | 14/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5466125 | 0.87 | NR3C1 (0.51) | NR3C1PGRAR | |
| SCHEMBL3540965 | 0.85 | NR3C1 (0.82) | NR3C1PGRARTRPV1 | |
| SCHEMBL5460432 | 0.83 | NR3C1 (0.52) | NR3C1PGRARTRPV1 | |
| SCHEMBL5461513 | 0.80 | NR3C1 (0.51) | NR3C1PGRAR | |
| SCHEMBL5467910 | 0.80 | NR3C1 (0.40) | NR3C1PGRARTRPV1 | |
| SCHEMBL5452584 | 0.78 | NR3C1 (0.48) | NR3C1PGRARTRPV1 | |
| SCHEMBL5466482 | 0.77 | NR3C1 (0.51) | NR3C1PGRAR | |
| SCHEMBL5458848 | 0.77 | NR3C1 (0.68) | NR3C1PGRARTRPV1 | |
| SCHEMBL333048 | 0.77 | NR3C1 (0.77) | NR3C1PGRARTRPV1 | |
| SCHEMBL1260205 | 0.76 | NR3C1 (0.79) | NR3C1PGRARTRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070015750-A1 | Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents | BAEURLE STEFAN | 2007-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070015750-A1 | Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents | DHPS, TNF, PTGES | NR3C1 676/4885PGR 3316/4885AR 3651/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.